Article
Moderna’s investigational flu vaccine moves forward in FDA review
Bearish
-55.0
−100 Bearish
0
+100 Bullish
Moderna Inc (NASDAQ:MRNA, XETRA:0QF) announced that the US Food and Drug Administration (FDA) will initiate review of its investigational seasonal influenza vaccine, mRNA-1010, following a Type A meeting between the company and the agency. Shares of Moderna added 6.5% at about $47 on the...
Actions
Pulse AI
Pulse analysis not available yet. Click "Get Pulse" above.
Generated by Pulse AI, Glideslope's proprietary engine for interpreting market sentiment and economic signals. For informational purposes only — not financial advice.
Article Info
Source
finance.yahoo.com
Published
Feb 18, 2026 · 4:18 pm
Article ID
TXTKLKY
Original URL
Open source
Sentiment Signal
Bearish
-55.0
−100Neutral+100
More Like This